Note: This document has been translated from a part of the Japanese original for reference purposes only. The translation of the supplementary material on financial results will also be disclosed on May 29, 2026. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
May 15, 2026
Consolidated Financial Results for the Three Months Ended March 31, 2026 (Under Japanese GAAP)
Company name: ISEKI&CO., LTD. Listing: Tokyo Stock Exchange Securities code: 6310
URL: https://www.iseki.co.jp
Representative: Hajime Odagiri , President and Representative Director
Inquiries: Yoshikazu Ogusu , General Manager of Financial Department Telephone: +81-3-5604-7671
Scheduled date to commence dividend payments: -Preparation of supplementary material on financial results: Yes Holding of financial results briefing: Yes
(Yen amounts are rounded down to millions, unless otherwise noted.)
-
Consolidated financial results for the three months ended March 31, 2026 (from January 1, 2026 to March 31, 2026)
-
Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)
Net sales
Operating profit
Ordinary profit
Profit attributable to owners of parent
Three months ended
March 31, 2026
March 31, 2025
Millions of yen
51,471
46,177
%
11.5
5.0
Millions of yen
2,603
1,381
%
88.5
88.1
Millions of yen
2,552
980
%
160.4
6.5
Millions of yen
1,486
1,515
%
(1.9)
239.0
Note: Comprehensive income
For the three months ended March 31, 2026:
¥
2,629 million [
47.6%]
For the three months ended March 31, 2025:
¥
1,782 million [
14.2%]
Basic earnings per share
Diluted earnings per share
Three months ended
Yen
Yen
March 31, 2026
65.70
65.69
March 31, 2025
66.99
66.98
- Consolidated financial position
Total assets
Net assets
Equity-to-asset ratio
Net assets per share
As of
March 31, 2026
December 31, 2025
Millions of yen
221,885
209,475
Millions of yen
79,912
78,428
%
33.8
35.2
Yen
3,316.40
3,260.92
Reference: Equity
As of March 31, 2026:
¥
75,043 million
As of December 31, 2025:
¥
73,788 million
-
Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)
-
Cash dividends
Annual dividends per share
First quarter-end
Second quarter-end
Third quarter-end
Fiscal year-end
Total
Yen
Yen
Yen
Yen
Yen
Fiscal year ended December 31, 2025
-
-
-
40.00
40.00
Fiscal year ending December 31, 2026
-
Fiscal year ending December 31, 2026
(Forecast)
-
-
45.00
45.00
Note: Revisions to the forecast of cash dividends most recently announced: None
- Consolidated financial result forecasts for the fiscal year ending December 31, 2026 (from January 1, 2026 to December 31, 2026)
(Percentages indicate year-on-year changes.)
Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | Basic earnings per share | |||||
Full year | Millions of yen 180,000 | % (3.1) | Millions of yen 6,000 | % 42.0 | Millions of yen 4,900 | % 18.9 | Millions of yen 3,000 | % 8.8 | Yen 132.59 |
Note: Revisions to the financial result forecast most recently announced: | None | |
* Notes (1) Significant changes in the scope of consolidation during the period: | None | |
Newly included: - companies( | ) | |
Excluded: - companies( | ) |
Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: None
Changes in accounting policies, changes in accounting estimates, and restatement
Changes in accounting policies due to revisions to accounting standards and other regulations: None
Changes in accounting policies due to other reasons: None
Changes in accounting estimates: None
Restatement: None
Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of March 31, 2026
22,984,993 shares
As of December 31, 2025
22,984,993 shares
Number of treasury shares at the end of the period
As of March 31, 2026
356,898 shares
As of December 31, 2025
356,878 shares
Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)
Three months ended March 31, 2026 | 22,628,102 shares |
Three months ended March 31, 2025 | 22,622,190 shares |
The total number of treasury shares at the end of the period includes the Company's shares held by the "Board Benefit Trust" (245,400 shares for the period ended March 31, 2026, 245,400 shares for the period ended December 31, 2025). In addition, the Company's shares held by the "Board Benefit Trust" are included in the number of treasury shares deducted for the calculation of the average number of shares during the period.
Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public accountants or an audit firm: Yes(voluntary)
Quarterly Consolidated Financial Statements and Primary Notes Quarterly Consolidated Balance Sheet
(Millions of yen)
As of December 31, 2025 As of March 31, 2026
Assets
Cash and deposits 12,891 9,538
Current assets
Notes and accounts receivable - trade, and contract assets | 26,494 | 38,230 |
Merchandise and finished goods | 47,999 | 48,527 |
Work in process | 8,285 | 8,491 |
Raw materials and supplies | 1,457 | 1,469 |
Other | 5,417 | 4,703 |
Allowance for doubtful accounts | (113) | (154) |
Total current assets | 102,431 | 110,806 |
Non-current assets | ||
Property, plant and equipment | ||
Buildings and structures, net | 24,400 | 24,104 |
Land | 43,607 | 43,468 |
Other, net | 15,637 | 17,943 |
Total property, plant and equipment | 83,645 | 85,516 |
Intangible assets | 3,970 | 4,101 |
Investments and other assets | ||
Investment securities | 13,200 | 14,565 |
Retirement benefit asset | 5,175 | 5,812 |
Other | 1,850 | 1,831 |
Allowance for doubtful accounts | (797) | (749) |
Total investments and other assets | 19,428 | 21,460 |
Total non-current assets | 107,044 | 111,079 |
Total assets | 209,475 | 221,885 |
(Millions of yen) As of December 31, 2025 As of March 31, 2026
Liabilities
Current liabilities
Notes and accounts payable - trade | 11,918 | 16,947 |
Electronically recorded obligations - operating | 15,005 | 11,900 |
Short-term loans payable | 28,738 | 39,215 |
Current portion of long-term loans payable | 9,359 | 8,910 |
Income taxes payable | 917 | 744 |
Provision for bonuses | 696 | 1,214 |
Accounts payable - other | 13,911 | 13,283 |
Other | 16,376 | 14,183 |
Total current liabilities | 96,922 | 106,398 |
Non-current liabilities | ||
Long-term loans payable | 16,898 | 16,227 |
Deferred tax liabilities for land revaluation | 4,122 | 4,089 |
Provision for retirement benefits for directors (and 165 161 other officers) | ||
Provision for share awards for directors (and other officers) | 43 | 50 |
Retirement benefit liability | 4,809 | 5,440 |
Asset retirement obligations | 1,011 | 1,008 |
Other | 7,073 | 8,597 |
Total non-current liabilities | 34,124 | 35,574 |
Total liabilities | 131,046 | 141,973 |
Net assets | ||
Shareholders' equity | ||
Share capital | 23,344 | 23,344 |
Capital surplus | 13,060 | 12,832 |
Retained earnings | 19,146 | 19,789 |
Treasury shares | (577) | (577) |
Total shareholders' equity | 54,973 | 55,389 |
Accumulated other comprehensive income | ||
Valuation difference on available-for-sale securities | 5,866 | 6,801 |
Deferred gains or losses on hedges | (70) | (13) |
Revaluation reserve for land | 8,503 | 8,431 |
Foreign currency translation adjustment | 3,014 | 2,992 |
Remeasurements of defined benefit plans | 1,500 | 1,441 |
Total accumulated other comprehensive income | 18,814 | 19,654 |
Subscription rights to shares | 8 | 8 |
Non-controlling interests | 4,631 | 4,860 |
Total net assets | 78,428 | 79,912 |
Total liabilities and net assets | 209,475 | 221,885 |
Quarterly Consolidated Statements of Income and Comprehensive Income
Quarterly Consolidated Statement of Income
For the Three-Month Period | ||
(Millions of yen) | ||
For the three months ended March 31, 2025 | For the three months ended March 31, 2026 | |
Net sales | 46,177 | 51,471 |
Cost of sales | 32,374 | 35,492 |
Gross profit | 13,803 | 15,978 |
Selling, general and administrative expenses | 12,421 | 13,375 |
Operating profit | 1,381 | 2,603 |
Non-operating income | ||
Interest income | 46 | 52 |
Dividend income | 25 | 27 |
Foreign exchange gains | - | 81 |
Other | 155 | 200 |
Total non-operating income | 227 | 362 |
Non-operating expenses | ||
Interest expenses | 379 | 363 |
Foreign exchange losses | 188 | - |
Commission for syndicated loans | 18 | 15 |
Other | 42 | 33 |
Total non-operating expenses | 628 | 412 |
Ordinary profit | 980 | 2,552 |
Extraordinary income | ||
Gain on sale of non-current assets | 872 | 55 |
Total extraordinary income | 872 | 55 |
Extraordinary losses | ||
Loss on sale and retirement of non-current assets | 22 | 50 |
Impairment losses | - | 128 |
Total extraordinary losses | 22 | 178 |
Profit before income taxes | 1,830 | 2,429 |
Income taxes - current | 499 | 807 |
Income taxes - deferred | (256) | (98) |
Total income taxes | 243 | 709 |
Profit | 1,587 | 1,719 |
Profit attributable to non-controlling interests | 71 | 232 |
Profit attributable to owners of parent | 1,515 | 1,486 |
Quarterly Consolidated Statement of Comprehensive Income
For the Three-Month Period | ||
(Millions of yen) | ||
For the three months ended March 31, 2025 | For the three months ended March 31, 2026 | |
Profit | 1,587 | 1,719 |
Other comprehensive income | ||
Valuation difference on available-for-sale securities | 678 | 936 |
Deferred gains or losses on hedges | 8 | 70 |
Revaluation reserve for land | (118) | - |
Foreign currency translation adjustment | (324) | (37) |
Remeasurements of defined benefit plans, net of tax | (49) | (59) |
Total other comprehensive income | 195 | 910 |
Comprehensive income | 1,782 | 2,629 |
Comprehensive income attributable to | ||
Comprehensive income attributable to owners of 1,770 2,398 parent | ||
Comprehensive income attributable to non-controlling interests
11 231
Quarterly Consolidated Statement of Cash Flows
(Millions of yen)
For the three months ended March 31, 2026
Cash flows from operating activities
Depreciation 1,310
Profit before income taxes 2,429
Decrease (increase) in retirement benefit asset (636)
Impairment losses 128
Interest and dividend income (79)
Increase (decrease) in retirement benefit liability 630
Interest expenses 363
Decrease (increase) in trade receivables (11,732)
Foreign exchange losses (gains) (282)
Loss (gain) on sale of property, plant and equipment and intangible assets
(5)
Increase (decrease) in trade payables 1,888
Decrease (increase) in inventories (704)
Other, net (376)
Increase (decrease) in accounts payable - other 77
Interest and dividends received 79
Subtotal (6,989)
Payments for business structure reform expenses (562)
Interest paid (371)
Income taxes paid (987)
Return of subsidy (101)
Net cash provided by (used in) operating activities (8,933)
Cash flows from investing activities
Proceeds from sale of property, plant and equipment and intangible assets
145
Purchase of property, plant and equipment and intangible assets
(2,563)
Decrease (increase) in loans receivable (25)
Purchase of investment securities (0)
Other, net (23)
Decrease (increase) in time deposits (199)
Net cash provided by (used in) investing activities (2,667)
Net cash provided by (used in) financing activities 7,764
Cash flows from financing activities | |
Net increase (decrease) in short-term loans payable | 10,405 |
Proceeds from long-term loans payable | 1,000 |
Repayments of long-term loans payable | (2,146) |
Proceeds from sale and leaseback transactions | 51 |
Repayments of lease liabilities | (361) |
Purchase of treasury shares | (0) |
Dividends paid | (853) |
Dividends paid to non-controlling interests | (2) |
Purchase of shares of subsidiaries not resulting in change in scope of consolidation
(327)
Effect of exchange rate change on cash and cash equivalents | 283 |
Net increase (decrease) in cash and cash equivalents | (3,551) |
Cash and cash equivalents at beginning of period | 12,840 |
Cash and cash equivalents at end of period | 9,288 |